Ncs Healthcare recalls
Ncs Healthcare appears in 3 official U.S. recall notices indexed by RecallRadar, most recently on 2023-11-29.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 3 |
|---|---|
| Published | 2020-02-26 to 2023-11-29 |
| By agency | FDA Drug (3) |
| By classification | Class III (2), Class II (1) |
| By status | terminated (3) |
| Distribution named in notices | US |
Recalls
- Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blister card (NDC 0615-8255-39), Rx only…
FDA Drug · Class III · 2023-11-29 · Ncs Healthcare
Reason: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots - Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39)…
FDA Drug · Class III · 2023-11-29 · Ncs Healthcare
Reason: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots - Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141
FDA Drug · Class II · 2020-02-26 · Ncs Healthcare
Reason: Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.